Search research articles
Contact Us
Filters
Showing results (261-270 of 359) with videos related to
Page
of 36
Sort By:
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
CELLULAR RNA INTERACTS WITH MAVS TO PROMOTE ANTIVIRAL SIGNALING
Nandan S Gokhale, Kim Somfleth, Matthew G Thompson, et al.
The American Journal of Pathology
|
April 15, 2014
IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice
Kirsten M Spann, Zhixuan Loh, Jason P Lynch, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Cell
|
October 5, 2006
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival
Yuchen Chien, Sungchan Kim, Ron Bumeister, et al.
The Journal of Infectious Diseases
|
July 19, 2023
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
Charlotte Hedskog, Lauren Rodriguez, Pavitra Roychoudhury, et al.
Plos Pathogens
|
August 16, 2019
STING is required for host defense against neuropathological West Nile virus infection
Kathryn McGuckin Wuertz, Piper M Treuting, Emily A Hemann, et al.
Nature Immunology
|
November 20, 2019
RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions
Johannes Schwerk, Frank W Soveg, Andrew P Ryan, et al.
Gastroenterology
|
December 22, 2011
A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses
Stephen J Polyak, Chihiro Morishima, John D Scott, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 2023
Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2
Jolie M Phan, Erik D Layton, Krystle K Q Yu, et al.
Elife
|
February 22, 2022
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 359) with videos related to
Sort By:
Page
of 36
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
CELLULAR RNA INTERACTS WITH MAVS TO PROMOTE ANTIVIRAL SIGNALING
Nandan S Gokhale, Kim Somfleth, Matthew G Thompson, et al.
The American Journal of Pathology
|
April 15, 2014
IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice
Kirsten M Spann, Zhixuan Loh, Jason P Lynch, et al.
Biorxiv : the Preprint Server for Biology
|
December 21, 2021
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Cell
|
October 5, 2006
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival
Yuchen Chien, Sungchan Kim, Ron Bumeister, et al.
The Journal of Infectious Diseases
|
July 19, 2023
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
Charlotte Hedskog, Lauren Rodriguez, Pavitra Roychoudhury, et al.
Plos Pathogens
|
August 16, 2019
STING is required for host defense against neuropathological West Nile virus infection
Kathryn McGuckin Wuertz, Piper M Treuting, Emily A Hemann, et al.
Nature Immunology
|
November 20, 2019
RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions
Johannes Schwerk, Frank W Soveg, Andrew P Ryan, et al.
Gastroenterology
|
December 22, 2011
A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses
Stephen J Polyak, Chihiro Morishima, John D Scott, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 2023
Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2
Jolie M Phan, Erik D Layton, Krystle K Q Yu, et al.
Elife
|
February 22, 2022
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
David W Hawman, Kimberly Meade-White, Jacob Archer, et al.
Page
of 36